← Eichor
Condition: Hpv Associated Oropharyngeal Squamous Cell Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hpv Associated Oropharyngeal Squamous Cell Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Phase N/A · 3 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT04564989Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT07513389Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Phase 2 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06323460Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
Phase 1 · 1 location(s) · Ryan Carey · NCT06747390Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide C
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06821243A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papil
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05307939Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT03875716Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer
Phase 1 · 1 location(s) · BlueSky Immunotherapies GmbH · NCT06589609CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
Phase 2 · 1 location(s) · Yale University · NCT07172256Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Co
Phase N/A · 1 location(s) · Mayo Clinic · NCT06115772Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subject
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06223568A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.
Phase 1/Phase 2 · 2 location(s) · Cellid Co., Ltd. · NCT06797986E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Phase 2 · 3 location(s) · Christian Hinrichs · NCT05686226De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)
NA · 1 location(s) · Royal North Shore Hospital · NCT06307015E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Phase 1/Phase 2 · 2 location(s) · Christian Hinrichs · NCT05639972Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
Phase 2 · 2 location(s) · Jonathan Schoenfeld, MD, MPH · NCT04900623A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Phase 1/Phase 2 · 4 location(s) · Theravectys S.A. · NCT06319963
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.